• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Vemedia Pharma NV

+ Add to Watchlist

VEPVP:BB

Price not available for VEPVP:BB

Snapshot for Vemedia Pharma NV (VEPVP)

Open: - Day's Range: - Volume: 0
Previous Close: 2.4400 52wk Range: - 1-Yr Rtn: -

Stock Chart for VEPVP

No chart data available.
  • VEPVP:BB
  • 1M
  • 1Y
2.4400
Interactive VEPVP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VEPVP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. BEL20 -
Earnings Per Share (ttm) 0.1090
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 36.09
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VEPVP

No data available

Company Profile & Key Executives for VEPVP

Vemedia Pharma NV develops pharmaceuticals. The Company manufactures and provides a variety of self-medicated drug therapies for the treatment of a variety of conditions including migrain, constipation, teething, persisitent cough, and muscle pain, in table, film-coated tablets, and capsules. Vemedia Pharma conducts business worldwide.

Yvan VindevogelChief Executive OfficerRob DrenthChief Operating Officer
Jean Yves De VelChief Financial OfficerNico AlbertsVP:Business Development
More Company Profile & Key Executives for VEPVP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil